Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 4/2015

01-12-2015 | Original Article

The prevalence of metabolic syndrome in polycystic ovary syndrome in a South Indian population and the use of neck circumference in defining metabolic syndrome

Authors: Binu Parameswaran Pillai, Prasanna, Harish Kumar, Rohini Vilasam Jayakumar, Varun Chandra Alur, V.S. Sheejamol

Published in: International Journal of Diabetes in Developing Countries | Issue 4/2015

Login to get access

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine disorder in young women with a high prevalence of insulin resistance (IR) and metabolic syndrome (MetS). The prevalence of MetS differs based on the defining criteria used. Neck circumference (NC) has been proposed as a surrogate marker of MetS which is simple and easy to perform in the outpatient setting. The aim of the study was to estimate the prevalence of metabolic syndrome in women with PCOS and to study the use of NC in defining metabolic syndrome. This was a prospective observational cross-sectional study involving 121 PCOS patients over a period of 2 years. The prevalence of metabolic syndrome was estimated using the modified Adult Treatment Panel (ATP) III criteria as well as the International Diabetes Federation (IDF) criteria. The Pearson correlation coefficient was used to find the degree of correlation between NC and waist circumference (WC). The Receiver operating characteristic (ROC) curves of NC were used to predict the metabolic syndrome. The independent sample t test and the Mann-Whitney U test were used for comparing the average NC and WC between the groups of patients with and without MetS. The prevalence of MetS was found to be 30.6 % using the modified ATP III criteria and 52 % using the IDF criteria. There is a statistically significant positive correlation between NC and WC (r = 0.758, p < 0.001). The mean NC is higher in patients who have MetS by both criteria (p < 0.001). Based on ROC curve analysis, the NC cutoff of 33.5 cm detected MetS (by IDF criteria) with a sensitivity of 60.3 % and a specificity of 70.7 % (area under ROC curve = 0.70, p < 0.001) and the NC cutoff of 33.87 cm detected MetS (by ATP III criteria) with a sensitivity of 73 % and a specificity of 69 % (area under ROC curve = 0.722 p < 0.001). The IDF criteria identified a higher number of PCOS subjects with MetS compared to the ATP III criteria. NC correlated very well with MetS as well as WC, and this could replace the waist circumference to define MetS in the future.
Literature
1.
go back to reference Azziz R et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89(6):2745–9.CrossRefPubMed Azziz R et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89(6):2745–9.CrossRefPubMed
2.
go back to reference Hart R, Hickey M, Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18(5):671–83.CrossRefPubMed Hart R, Hickey M, Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18(5):671–83.CrossRefPubMed
3.
go back to reference Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–7.CrossRef Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–7.CrossRef
4.
go back to reference Azziz R et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456–88.CrossRefPubMed Azziz R et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456–88.CrossRefPubMed
5.
go back to reference Glueck CJ et al. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism. 2003;52(7):908–15.CrossRefPubMed Glueck CJ et al. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism. 2003;52(7):908–15.CrossRefPubMed
6.
go back to reference Rosenfield RL. Evidence that idiopathic functional adrenal hyperandrogenism is caused by dysregulation of adrenal steroidogenesis and that hyperinsulinemia may be involved. J Clin Endocrinol Metab. 1996;81(3):878–80.PubMed Rosenfield RL. Evidence that idiopathic functional adrenal hyperandrogenism is caused by dysregulation of adrenal steroidogenesis and that hyperinsulinemia may be involved. J Clin Endocrinol Metab. 1996;81(3):878–80.PubMed
7.
go back to reference Nestler JE et al. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 1998;83(6):2001–5.PubMed Nestler JE et al. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 1998;83(6):2001–5.PubMed
9.
go back to reference Carmina E et al. Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Hum Reprod. 2003;18(11):2289–93.CrossRefPubMed Carmina E et al. Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Hum Reprod. 2003;18(11):2289–93.CrossRefPubMed
10.
go back to reference Mandrelle K et al. Prevalence of metabolic syndrome in women with polycystic ovary syndrome attending an infertility clinic in a tertiary care hospital in South India. J Hum Reprod Sci. 2012;5(1):26–31.PubMedCentralCrossRefPubMed Mandrelle K et al. Prevalence of metabolic syndrome in women with polycystic ovary syndrome attending an infertility clinic in a tertiary care hospital in South India. J Hum Reprod Sci. 2012;5(1):26–31.PubMedCentralCrossRefPubMed
11.
go back to reference Dey R et al. Association of metabolic syndrome in polycystic ovarian syndrome: an observational study. J Obstet Gynaecol India. 2011;61(2):176–81.PubMedCentralCrossRef Dey R et al. Association of metabolic syndrome in polycystic ovarian syndrome: an observational study. J Obstet Gynaecol India. 2011;61(2):176–81.PubMedCentralCrossRef
12.
go back to reference Weerakiet S et al. Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: using the International Diabetes Federation criteria. Gynecol Endocrinol. 2007;23(3):153–60.CrossRefPubMed Weerakiet S et al. Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: using the International Diabetes Federation criteria. Gynecol Endocrinol. 2007;23(3):153–60.CrossRefPubMed
13.
go back to reference Deepa M et al. Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev. 2007;23(2):127–34.CrossRefPubMed Deepa M et al. Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev. 2007;23(2):127–34.CrossRefPubMed
14.
go back to reference Bener A et al. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study. Metab Syndr Relat Disord. 2009;7(3):221–9.CrossRefPubMed Bener A et al. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study. Metab Syndr Relat Disord. 2009;7(3):221–9.CrossRefPubMed
15.
go back to reference Athyros VG et al. The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Curr Med Res Opin. 2005;21(8):1157–9.CrossRefPubMed Athyros VG et al. The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Curr Med Res Opin. 2005;21(8):1157–9.CrossRefPubMed
16.
go back to reference Saely CH et al. Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography. Diabetes Care. 2006;29(4):901–7.CrossRefPubMed Saely CH et al. Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography. Diabetes Care. 2006;29(4):901–7.CrossRefPubMed
17.
go back to reference Monami M et al. IDF and ATP-III definitions of metabolic syndrome in the prediction of all-cause mortality in type 2 diabetic patients. Diabetes Obes Metab. 2007;9(3):350–3.CrossRefPubMed Monami M et al. IDF and ATP-III definitions of metabolic syndrome in the prediction of all-cause mortality in type 2 diabetic patients. Diabetes Obes Metab. 2007;9(3):350–3.CrossRefPubMed
18.
go back to reference Tong PC et al. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program’s Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care. 2007;30(5):1206–11.CrossRefPubMed Tong PC et al. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program’s Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care. 2007;30(5):1206–11.CrossRefPubMed
19.
go back to reference de Simone G et al. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study. Diabetes Care. 2007;30(7):1851–6.CrossRefPubMed de Simone G et al. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study. Diabetes Care. 2007;30(7):1851–6.CrossRefPubMed
20.
go back to reference Yang GR et al. Neck circumference positively related with central obesity, overweight, and metabolic syndrome in Chinese subjects with type 2 diabetes: Beijing Community Diabetes Study 4. Diabetes Care. 2010;33(11):2465–7.PubMedCentralCrossRefPubMed Yang GR et al. Neck circumference positively related with central obesity, overweight, and metabolic syndrome in Chinese subjects with type 2 diabetes: Beijing Community Diabetes Study 4. Diabetes Care. 2010;33(11):2465–7.PubMedCentralCrossRefPubMed
21.
go back to reference Carmina E et al. Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS. Eur J Endocrinol. 2006;154(1):141–5.CrossRefPubMed Carmina E et al. Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS. Eur J Endocrinol. 2006;154(1):141–5.CrossRefPubMed
Metadata
Title
The prevalence of metabolic syndrome in polycystic ovary syndrome in a South Indian population and the use of neck circumference in defining metabolic syndrome
Authors
Binu Parameswaran Pillai
Prasanna
Harish Kumar
Rohini Vilasam Jayakumar
Varun Chandra Alur
V.S. Sheejamol
Publication date
01-12-2015
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 4/2015
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-015-0319-y

Other articles of this Issue 4/2015

International Journal of Diabetes in Developing Countries 4/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.